Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: S&P Capital IQ – STARS Reports
$127.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Saudi Pharmaceutical Industries and Medical Appliances Corp SJSC Signs Marketing and Distribution Agreement with Glaxosmithkline Plc


Tuesday, 5 Nov 2013 07:34am EST 

Saudi Pharmaceutical Industries and Medical Appliances Corp SJSC announced that it has signed a joint marketing agreement for five years period with Glaxosmithkline Plc. Under the terms of the agreement the Company will get the rights of marketing, selling and distributing of Raspira Formula within the Kingdom of Saudi Arabia, a brand name synonymous with Seretide product which is produced and marketed by Glaxosmithkline Plc. The Company is expected to put the product in the local market during the first half of 2014. 

Company Quote

46.89
-0.13 -0.28%
15 Aug 2014